已收盤 11-06 16:00:00 美东时间
-10.390
-12.76%
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Mircea Dobre downgraded Helios Technologies Inc (NYSE:HLIO) from Outperform to Neut...
11-06 21:18
BMO Capital analyst Vik Chopra downgrades Globus Medical (NYSE:GMED) from Outperform to Market Perform and lowers the price target from $94 to $78.
11-06 19:02
摘要【2026W45-Vol.122】 1. 史赛克Q3不及预期下调全年指引 2. 西门子医疗拟更名,正式去除西门子字样,独立分拆诊断业务 3. 飞利浦计提...
11-06 18:00
华盛资讯11月6日讯,Globus Medical公布2026财年Q3业绩,公司Q3营收7.64亿美元,同比下降0.7%,归母净利润1.41亿美元,同比增长18.7%。
11-06 08:19
华盛资讯11月6日讯,Globus Medical公布2026财年Q3业绩,公司Q3营收7.64亿美元,同比下降0.7%,归母净利润1.41亿美元,同比增长18.7%。
11-06 06:17
Globus Medical ( ($GMED) ) just unveiled an update. On November 5, 2026, Globus...
11-06 05:53
Globus Medical (NYSE:GMED) affirms FY2026 Adj EPS guidance from $4.95-$5.05 to $4.95-$5.05 vs $5.00 analyst estimate. Lowers FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.090 billion vs $3.199 billion estimate.
11-06 05:04
Globus Medical, Inc. a leading musculoskeletal technology company, today announced that it completed the acquisition of Synaptive Medical, deepening the Company's presence in cranial neurosurgery and positioning it for further growth in this market.
11-04 05:02
Globus Medical completed the acquisition of Synaptive Medical on August 4, 2026, enhancing its presence in cranial neurosurgery. Synaptive specializes in surgical visualization, navigation, planning, and MRI technologies. The acquisition strengthens Globus' portfolio and positions it for growth in neurosurgery, combining Synaptive's solutions with its Excelsius ecosystem. Globus prioritizes continuity for Synaptive customers and plans to integrat...
11-03 21:02
11月3日,Globus Medical Inc(GMED)收涨1.81%,报79.46美元,成交额1.21亿美元,市值106.68亿美元。 行情数据 • 开盘...
11-03 05:52